[TREATMENT OF OTOTOXIC MANIFESTATIONS DUE TO ANTITUBERCULAR ANTIBIOTIC THERAPY. CLINICAL USE OF A MONOAMINE OXIDASE INHIBITOR (NIALAMIDE)].
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D001299:Audiometry; D003056:Cochlear Nerve; D003638:Deafness; D004096:Dihydrostreptomycin Sulfate; D007612:Kanamycin; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide; D013307:Streptomycin / Q000009:adverse effects*; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary; D014717:Vertigo; D014725:Vestibular Nerve; D014756:Viomycin
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D008996:Monoamine Oxidase Inhibitors; D007612:Kanamycin; D009526:Nialamide; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin; D014756:Viomycin
AUDIOMETRY; COCHLEAR NERVE; DEAFNESS; DIHYDROSTREPTOMYCIN; KANAMYCIN; NIALAMIDE; STREPTOMYCIN TOXICOLOGY; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY; VERTIGO; VESTIBULAR NERVE; VIOMYCIN
TRATTAMENTO DELLE MANIFESTAZIONI OTOTOSSICHE DA ANTIBIOTICOTERAPIA ANTITUBERCOLARE. IMPIEGO CLINICO DI UN ANTI-MAO (NIALAMIDE)